二期翻修全膝关节置换术治疗假体周围感染中髌骨的命运与相关性
单中心回顾性研究纳入103例因全膝关节置换术后假体周围感染行二期翻修的患者,比较再植入时使用与不使用髌骨假体两组。平均随访33.5个月,两组患者报告结局指标(PROMs)及假体生存率均无显著差异(P≥.156和P≥.342)。作者认为髌骨置换似乎不显著影响术后PROMs或生存率,鉴于伸膝装置并发症风险,术者可选择不植入髌骨假体而预期相似临床结局。
要点
- 103例二期翻修中41.7%再植入髌骨假体、58.3%未植入,两组PROMs无显著差异(P≥.156)。
- 平均随访33.5个月、最长75个月,两组全因、无菌性及感染性生存率均无显著差异(P≥.342)。
- 髌骨倾斜度与移位变化两组无显著差异(P=.504和P=.097)。
核心结论
- 再植入时行髌骨置换似乎不显著影响术后PROMs或假体生存率。
- 鉴于髌骨置换存在伸膝装置并发症风险,术者可选择不植入髌骨假体而预期相似临床结局。
研究设计与样本
- 单中心回顾性研究,由三位术者完成的膝关节假体周围感染二期翻修病例。
- 共103例符合纳入标准,再植入时使用髌骨假体43例(41.7%)、未使用60例(58.3%)。
- 切除阶段移除所有原髌骨假体及骨水泥,再植入时尽可能行髌骨置换。
- 比较两组PROMs、假体生存率及影像学测量(髌骨倾斜与移位)。
- 证据等级为III级。
主要发现
- 平均随访33.5个月,两组患者人口学特征及PROMs均无显著差异(P≥.156)。
- 最长随访75个月,Kaplan-Meier估计的全因、无菌性及感染性生存率两组均无显著差异(P≥.342)。
- 髌骨倾斜度(切除前至再植入后变化)两组无显著差异(P=.504)。
- 髌骨移位(切除前至再植入后变化)两组无显著差异(P=.097)。
临床怎么用
- 作者认为,鉴于髌骨置换存在伸膝装置并发症风险,术者在全膝再植入时可选择不植入髌骨假体并预期相似临床结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It remains unclear whether reimplantation of a patellar component during a two-stage revision for periprosthetic total knee arthroplasty infection (PJI) affects patient reported outcome measures (PROMs) or implant survivorship. The purpose of this study was to evaluate whether patellar resurfacing during reimplantation confers a functional benefit or increases implant survivorship after two-stage treatment for PJI. METHODS: Two-stage revisions for knee PJI performed by three surgeons at a single tertiary care center were reviewed retrospectively. All original patellar components and cement were removed during resection and the patella was resurfaced whenever feasible during reimplantation. PROMs, implant survivorship, and radiographic measurements (patellar tilt and displacement) were compared between knees reimplanted with a patellar component versus those without a patellar component. RESULTS: A total of 103 patients met the inclusion criteria. Forty-three patients (41.7%) underwent reimplantation with, and 60 patients (58.3%) without a patellar component. At a mean follow-up of 33.5 months, there were no significant differences in patient demographics or PROMs between groups (P ≥ .156). No significant differences were found in the estimated Kaplan-Meier all-cause, aseptic, or septic survivorship between groups (P ≥ .342) at a maximum of 75 months follow-up. There was no significant difference in the change (pre-resection to post-reimplant) of patellar tilt (P = .504) or displacement (P = .097) between the groups. CONCLUSION: Patellar resurfacing during knee reimplantation does not appear to meaningfully impact postoperative PROMs or survivorship. Given the risk of potential extensor mechanism complications with patellar resurfacing, surgeons may choose to leave the patella without an implant during total knee reimplantation and expect similar clinical outcomes. LEVEL OF EVIDENCE: Level III.
引用
- Buller LT, Eccles CJ, Deckard ER, et al. The Fate and Relevance of the Patella in Two-Stage Revision Total Knee Arthroplasty for Periprosthetic Joint Infection. J Arthroplasty. 2022. PMID: 35533823. doi:10.1016/j.arth.2022.05.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。